| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2020-12-19 23:40 Tx date 2020-12-16 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$134,750
+35,000 vol $3.85 each |
80,453 | |
| Filed 2020-12-19 23:32 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,454,547 vol |
45,453 | |
| Filed 2020-12-19 22:43 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-193,941 vol |
6,059 | |
| Filed 2020-12-18 14:20 Tx date 2020-12-16 |
$IN
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$231,000
+60,000 vol $3.85 each |
90,303 | |
| Filed 2020-12-18 14:16 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-969,697 vol |
30,303 | |
| Filed 2020-12-18 13:48 Tx date 2020-12-16 |
$IN
InMed Pharmaceuticals Inc. |
Cutler, Adam
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
39,425 | |
| Filed 2020-12-17 17:06 Tx date 2020-12-16 |
$IN
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
61,060 | |
| Filed 2020-12-17 16:59 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-993,940 vol |
31,060 | |
| Filed 2020-12-17 16:14 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-16,970 vol |
530 | |
| Filed 2020-12-17 14:52 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-40,728 vol |
1,272 | |
| Filed 2020-12-17 14:32 Tx date 2020-12-16 |
$IN
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+35,000 vol |
81,969 | |
| Filed 2020-12-17 14:26 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,503,031 vol |
46,969 | |
| Filed 2020-12-17 13:41 Tx date 2020-12-16 |
$IN
InMed Pharmaceuticals Inc. |
Sazdanoff, Catherine
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+18,000 vol |
22,091 | |
| Filed 2020-12-17 13:38 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Sazdanoff, Catherine
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-130,909 vol |
4,091 | |
| Filed 2020-12-17 12:07 Tx date 2020-12-16 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
33,364 | |
| Filed 2020-12-17 12:04 Tx date 2020-12-16 |
$IN
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
39,425 | |
| Filed 2020-12-17 11:42 Tx date 2020-12-16 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
347,424 | |
| Filed 2020-12-03 16:19 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-606,061 vol |
18,939 | |
| Filed 2020-12-03 16:09 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,037,575 vol |
32,425 | |
| Filed 2020-12-03 15:18 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-48,485 vol |
1,515 |